Data From Clinical Studies of bioTheranostics’ CancerTYPE ID® and Breast …
ASCO Abstract Numbers 573, 530 and 21103 SAN DIEGO, June 7, 2011 /PRNewswire/ — bioTheranostics, Inc., a bioMerieux association that develops innovative oncology evidence tests to expostulate...
View ArticleMBCS: Trastuzumab Costliest Advanced Breast Cancer Tx
SAN FRANCISCO — Regimens that enclose trastuzumab (Herceptin) are a many costly in a metastatic breast cancer armamentarium, attention researchers found. Costs for patients holding trastuzumab averaged...
View ArticleHerceptin Boosts Breast Cancer Survival, Investigate Says
Breast cancer that is rarely assertive though held early appears to be best treated with a multiple of Herceptin and chemotherapy, according to a investigate expelled Wednesday. UCLA researchers...
View ArticleScottish Medicines Consortium Rules Against Breast Cancer Treatment...
HATFIELD, England, October 10, 2011 /PRNewswire/ – - Scottish women with metastatic breast cancer denied entrance to life-prolonging treatment The Scottish Medicines Consortium (SMC) announced now...
View ArticleWomen With Advanced Breast Cancer Denied Life-Extending Treatment Halaven(R)...
HATFIELD, England , Nov 17, 2011 /PRNewswire/ – Eisai Considers Grounds to Appeal a NICE Decision The National Institute for Health and Clinical Excellence (NICE) now published a final estimation...
View ArticleAdherex Provides Patient Enrollment Update for Phase 2 Study of Eniluracil in …
RESEARCH TRIANGLE PARK, NORTH CAROLINA, Jan 09, 2012 (MARKETWIRE around COMTEX) – Adherex Technologies Inc. /quotes/zigman/6419483 CA:AHX -28.79% (pinksheets:ADHXF), a biopharmaceutical association...
View ArticleNew Breast Cancer Treatment Available in Italy
HATFIELD, England, Jan 26, 2012 /PRNewswire/ – Halaven(R) (eribulin) increases life expectancies for women with locally modernized or metastatic breast cancer Halaven(R) (eribulin), a novel diagnosis...
View ArticleNew Breast Cancer Treatment Available in France
<!– finish javascript to email a article –> PR Newswire HATFIELD, England, Jul 10, 2012 /PRNewswire/ – Reimbursement postulated for Halaven(R) (eribulin) for women with locally modernized or...
View ArticleEisai Expands in Israeli Market With Approval of Halaven
Hatfield, England (ots/PRNewswire) - Metastatic breast cancer diagnosis Halaven(R) (eribulin) provides a statistically poignant altogether presence advantage for women with a disease Halaven(R)...
View ArticleTrastuzumab Ups Cardiac Risk for Older Women With Breast Cancer
For comparison women with early-stage breast cancer, diagnosis with trastuzumab correlates with increasing rates of heart disaster and cardiomyopathy, according to a investigate published online Nov....
View Article
